See the DrugPatentWatch profile for clonazepam

Based on the information available, there is no explicit mention of Aurobindo Pharma providing training to their employees specifically on the storage and handling of Clonazepam. However, Aurobindo Pharma is known for its commitment to quality and compliance with regulations [1].

The company follows Good Manufacturing Practices (GMP) and has received several approvals from regulatory bodies such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and others [1]. These practices include stringent quality control measures for the storage and handling of all pharmaceutical products, including Clonazepam [2].

Moreover, Aurobindo Pharma is a signatory to the Industry Code of Conduct and adheres to the principles of the Pharmaceutical Supply Chain Initiative (PSCI) [1]. This indicates a commitment to ethical and responsible practices in all aspects of their operations, including the handling of pharmaceutical products.

In conclusion, while there is no specific information available about training on Clonazepam storage and handling, Aurobindo Pharma's commitment to quality, GMP compliance, and ethical practices suggests that their employees are likely trained on the proper handling and storage of all pharmaceutical products, including Clonazepam.

Sources:
[1] Aurobindo Pharma. (n.d.). About Us. Retrieved from https://www.aurobindo.com/about-us.html
[2] US Food and Drug Administration. (2019). Aurobindo Pharma Limited. Retrieved from https://www.fda.gov/industry/inspections-compliance-enforcement-and-criminal-investigations/aurobindo-pharma-limited
[3] DrugPatentWatch. (2021). Aurobindo Pharma. Retrieved from https://www.drugpatentwatch.com/aurobindo-pharma/